• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠类癌肿瘤的内镜治疗。

Endoscopic treatment of rectal carcinoid tumors.

机构信息

Center of Gastroenterology, Maebashi Red Cross Hospital, Maebashi, Japan.

出版信息

Dis Colon Rectum. 2010 Feb;53(2):169-76. doi: 10.1007/DCR.0b013e3181b9db7b.

DOI:10.1007/DCR.0b013e3181b9db7b
PMID:20087092
Abstract

BACKGROUND

Various methods have been reported for the endoscopic treatment of rectal carcinoid tumors. The present study was designed to identify the optimal treatment strategy for an endoscopic resection.

METHODS

Forty rectal carcinoid tumors of 38 patients were treated endoscopically. The indication criteria, complete resection rate, selection of treatment, local recurrence, distant metastases, and complications were analyzed. All tumors were estimated to measure 1 cm or less in diameter, without muscular invasion, atypical features, and lymph node metastases to the pararectal region.

RESULTS

Complete resection of the lesions was obtained in 75.0% (30/40). The complete resection rates were 20.0% (1/5) by conventional polypectomy, 84.6% (22/26) by a two-channel endoscopic mucosal resection, and 77.8% (7/9) by endoscopic submucosal dissection. The 10 cases that did not show a clear submucosal layer after initial endoscopic treatment received additional endoscopic microwave coagulation therapy. There were no local or distant recurrences in the followed-up periods (median, 6.4 years). No difference was observed in the complete resection rate between two-channel endoscopic mucosal resection and endoscopic submucosal dissection.

CONCLUSIONS

Small carcinoid tumors measuring less than 1 cm in diameter can therefore be managed endoscopically with no recurrence or spread. The selection of endoscopic treatment should be made after taking such factors as cost-effectiveness, expertise, and experience into careful consideration.

摘要

背景

各种方法已被报道用于直肠类癌肿瘤的内镜治疗。本研究旨在确定内镜切除的最佳治疗策略。

方法

对 38 例 40 个直肠类癌肿瘤患者进行了内镜治疗。分析了适应证标准、完全切除率、治疗选择、局部复发、远处转移和并发症。所有肿瘤估计直径为 1cm 或更小,无肌层侵犯、非典型特征和腹膜后淋巴结转移。

结果

75.0%(30/40)获得了病变的完全切除。常规息肉切除术的完全切除率为 20.0%(1/5),双腔内镜黏膜切除术为 84.6%(22/26),内镜黏膜下剥离术为 77.8%(7/9)。10 例初次内镜治疗后未见明显黏膜下层的患者接受了额外的内镜微波凝固治疗。随访期间无局部或远处复发(中位随访时间为 6.4 年)。双腔内镜黏膜切除术和内镜黏膜下剥离术的完全切除率无差异。

结论

因此,直径小于 1cm 的小类癌肿瘤可以通过内镜治疗而无复发或扩散。内镜治疗的选择应在充分考虑成本效益、专业知识和经验等因素后做出。

相似文献

1
Endoscopic treatment of rectal carcinoid tumors.直肠类癌肿瘤的内镜治疗。
Dis Colon Rectum. 2010 Feb;53(2):169-76. doi: 10.1007/DCR.0b013e3181b9db7b.
2
Endoscopic submucosal dissection or conventional endoscopic mucosal resection is an effective and safe treatment for rectal carcinoid tumors: a retrospective study.内镜下黏膜下剥离术或传统内镜黏膜切除术是治疗直肠类癌肿瘤的一种有效且安全的方法:一项回顾性研究。
J Laparoendosc Adv Surg Tech A. 2010 May;20(4):329-31. doi: 10.1089/lap.2009.0373.
3
Endoloop ligation after endoscopic mucosal resection using a transparent cap: A novel method to treat small rectal carcinoid tumors.经内镜黏膜切除术后使用透明帽行套扎结扎:一种治疗小直肠类癌瘤的新方法。
World J Gastroenterol. 2019 Mar 14;25(10):1259-1265. doi: 10.3748/wjg.v25.i10.1259.
4
Endoscopic submucosal dissection for treatment of rectal carcinoid tumors.内镜黏膜下剥离术治疗直肠类癌肿瘤。
Gastrointest Endosc. 2010 Jul;72(1):143-9. doi: 10.1016/j.gie.2010.01.040. Epub 2010 Apr 9.
5
Comparison of endoscopic resection therapies for rectal carcinoid tumor: endoscopic submucosal dissection versus endoscopic mucosal resection using band ligation.直肠类癌内镜下切除术的比较:内镜黏膜下剥离术与黏膜套扎切除术。
J Clin Gastroenterol. 2013 May-Jun;47(5):432-6. doi: 10.1097/MCG.0b013e31826faf2b.
6
Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography.直肠类癌肿瘤内镜下息肉切除术的适应证及内镜超声检查的临床应用价值
Dis Colon Rectum. 2005 Feb;48(2):285-91. doi: 10.1007/s10350-004-0765-y.
7
Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread.内镜切除分化良好的直肠类癌后考虑潜在淋巴转移的决策标准。
Endoscopy. 2011 Sep;43(9):790-5. doi: 10.1055/s-0030-1256414. Epub 2011 Jul 6.
8
Treatment outcomes of endoscopic resection for rectal carcinoid tumors: an analysis of the resectability and long-term results from 46 consecutive cases.直肠类癌肿瘤内镜切除的治疗结果:46例连续病例的可切除性及长期结果分析
Scand J Gastroenterol. 2016 Dec;51(12):1489-1494. doi: 10.1080/00365521.2016.1216591. Epub 2016 Aug 9.
9
Factors associated with complete local excision of small rectal carcinoid tumor.与小直肠类癌完全局部切除相关的因素。
Int J Colorectal Dis. 2013 Jan;28(1):57-61. doi: 10.1007/s00384-012-1538-z. Epub 2012 Jul 22.
10
Endoscopic submucosal dissection and preoperative assessment with endoscopic ultrasonography for the treatment of rectal carcinoid tumors.内镜黏膜下剥离术和超声内镜术前评估治疗直肠类癌肿瘤。
Surg Endosc. 2010 Jun;24(6):1413-9. doi: 10.1007/s00464-009-0791-x. Epub 2009 Dec 24.

引用本文的文献

1
Safety and Efficacy of Simplified EMR Versus ESD for Rectal Neuroendocrine Tumors ≤ 10 Mm: A Retrospective Cohort Study.简化内镜黏膜切除术与内镜黏膜下剥离术治疗直径≤10毫米直肠神经内分泌肿瘤的安全性和有效性:一项回顾性队列研究
J Clin Med. 2025 Aug 29;14(17):6125. doi: 10.3390/jcm14176125.
2
Traction-assisted endoscopic submucosal resection (TA-ESD) for rectal neuroendocrine tumors: a randomized multi-center trial.直肠神经内分泌肿瘤的牵引辅助内镜下黏膜下剥离术(TA-ESD):一项随机多中心试验。
Surg Endosc. 2025 Aug;39(8):5430-5438. doi: 10.1007/s00464-025-11934-8. Epub 2025 Jul 9.
3
Endoscopic full-thickness resection: A definitive solution for local complete resection of small rectal neuroendocrine neoplasms.
内镜全层切除术:小直肠神经内分泌肿瘤局部完整切除的确定性解决方案。
World J Gastroenterol. 2025 Mar 14;31(10):100444. doi: 10.3748/wjg.v31.i10.100444.
4
Comparative Efficacy and Acceptability of Endoscopic Methods for Rectal Neuroendocrine Neoplasms with Low Malignant Potential: A Network Meta-analysis.内镜治疗低恶性潜能直肠神经内分泌肿瘤的疗效和可接受性的比较:网状荟萃分析。
Turk J Gastroenterol. 2024 Jun;35(6):440-452. doi: 10.5152/tjg.2024.23477.
5
The role of endoscopic ultrasonography for diagnosis of residual rectal neuroendocrine tumor.内镜超声检查在直肠神经内分泌肿瘤残留诊断中的作用。
Surg Endosc. 2024 Aug;38(8):4260-4267. doi: 10.1007/s00464-024-10963-z. Epub 2024 Jun 12.
6
Risk factors for positive resection margins after endoscopic resection for gastrointestinal neuroendocrine tumors.内镜切除胃肠道神经内分泌肿瘤后切缘阳性的危险因素。
Surg Endosc. 2024 Apr;38(4):2041-2049. doi: 10.1007/s00464-024-10706-0. Epub 2024 Mar 1.
7
Efficacy of endoscopic mucosal resection versus endoscopic submucosal dissection for rectal neuroendocrine tumors ≤10mm: a systematic review and meta-analysis.内镜黏膜切除术与内镜黏膜下剥离术治疗直肠神经内分泌肿瘤≤10mm 的疗效比较:系统评价和荟萃分析。
Ann Saudi Med. 2023 May-Jun;43(3):179-195. doi: 10.5144/0256-4947.2023.179. Epub 2023 Jun 1.
8
Endoscopic treatment and management of rectal neuroendocrine tumors less than 10 mm in diameter.直径小于10毫米的直肠神经内分泌肿瘤的内镜治疗与管理
World J Gastrointest Endosc. 2023 Feb 16;15(2):19-31. doi: 10.4253/wjge.v15.i2.19.
9
Modified Cap-Assisted Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Rectal Neuroendocrine Tumors ≤10 mm: A Randomized Noninferiority Trial.改良帽辅助内镜下黏膜切除术与内镜黏膜下剥离术治疗直肠神经内分泌肿瘤≤10mm:一项随机非劣效性试验。
Am J Gastroenterol. 2022 Dec 1;117(12):1982-1989. doi: 10.14309/ajg.0000000000001914. Epub 2022 Aug 23.
10
Long-term clinical outcomes of endoscopic submucosal dissection in rectal neuroendocrine tumors based on resection margin status: a real-world study.基于切缘状态的直肠神经内分泌肿瘤内镜黏膜下剥离术的长期临床结局:一项真实世界研究
Surg Endosc. 2023 Apr;37(4):2644-2652. doi: 10.1007/s00464-022-09710-z. Epub 2022 Nov 15.